Stockscreener 앱 받기
8.44
4.52%
-0.40
시간 외 거래:
8.43
-0.010
-0.12%
Intellia Therapeutics Inc 주식(NTLA)의 최신 뉴스
Genome Engineering Market Generated Opportunities, Future - openPR.com
(NTLA) Long Term Investment Analysis - news.stocktradersdaily.com
Intellia Therapeutics Inc (NTLA) Has Recovered 31.71% From Its Low: Is This The Beginning Of A Trend? - Stocksregister
Intellia Therapeutics Inc [NTLA] Records 200-Day SMA of $15.05 - knoxdaily.com
Earnings Preview: Intellia Therapeutics, Inc. (NTLA) Q1 Earnings Expected to Decline - Yahoo Finance
Intellia Therapeutics, Inc. (NTLA) Recently Broke Out Above the 50-Day Moving Average - Yahoo Finance
Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2025 Earnings and Company Updates - The Manila Times
Leading CRISPR Pioneer Intellia Therapeutics to Reveal Q1 2025 Financial Results and Pipeline Updates - Stock Titan
The growth track for Intellia Therapeutics Inc (NTLA) has changed recently - Sete News
Company’s Banking Stock: Dissecting a -16.35% Quarterly Revenue Decline Amid Growth - investchronicle.com
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
Intellia Therapeutics Inc’s results are impressive - uspostnews.com
Wall Street Analysts Think Intellia Therapeutics (NTLA) Could Surge 392.81%: Read This Before Placing a Bet - Yahoo Finance
Upward Trajectory: Intellia Therapeutics Inc (NTLA) Posts a Gaine, Closing at 8.48 - DWinneX
Intellia Therapeutics Inc’s latest rating changes from various analysts - knoxdaily.com
Intellia Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your RightsNTLA - ACCESS Newswire
Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics, Offloads Meta Platforms - Benzinga
Cathie Wood’s ARK offloads Meta, boosts Intellia stock - Investing.com Australia
Cathie Wood’s ARK offloads Meta, boosts Intellia stock By Investing.com - Investing.com Canada
Is Intellia Therapeutics Inc (NASDAQ:NTLA) A Better Buy Than Others After A -62.53% Fall In This Year? - Marketing Sentinel
Insider Sale Alert: Intellia Therapeutics Inc [NTLA] – Is it Time to sell? - knoxdaily.com
Lawsuit for Investors in shares of Intellia Therapeutics, Inc. (NASDAQ: NTLA) announced by the Shareholders Foundation - Morningstar
Wolfe Research Upgrades Intellia Therapeutics (LSE:0JBU) - Nasdaq
Wolfe Research Upgrades Intellia Therapeutics (NTLA) - Nasdaq
Intellia Therapeutics shares up after Wolfe upgrade - MSN
Intellia Therapeutics Shares Rise After Upgrade From Wolfe Research - marketscreener.com
Intellia Therapeutics (NTLA) Surges After Upgrade from Wolfe Research - GuruFocus
NTLA’s price-to-free cash flow ratio: What it means for investors - uspostnews.com
Intellia Therapeutics (NTLA) Advances Nex-z in Phase III Trial f - GuruFocus
Intellia Therapeutics (NTLA) Receives Upgrade to Outperform from Wolfe Research | NTLA Stock News - GuruFocus
Intellia Therapeutics (NTLA) Eyes Growth with Gene Editing Advances - GuruFocus
Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday - Benzinga
New Horizons in Biomedical CRISPR Gene Editing Market Exploring - openPR.com
Wolfe Research Upgrades Intellia Therapeutics to Outperform From Peer Perform, Price Target is $21 - marketscreener.com
How the (NTLA) price action is used to our Advantage - news.stocktradersdaily.com
Intellia Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact The ... - Bluefield Daily Telegraph
Intellia Therapeutics, Inc. Sued for Securities Law - GlobeNewswire
Final Deadline Today for the Intellia Therapeutics, Inc. Securit - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesNTLA - PR Newswire
NTLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
Final Deadline Today for the Intellia Therapeutics, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsNTLA - The Malaysian Reserve
Class Action Filed Against Intellia Therapeutics, Inc. (NTLA)April 14, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics - Business Wire
FINAL REMINDER NTLA DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Intellia Therapeutics, Inc. Investors to Participate in the Class Action Lawsuit - markets.businessinsider.com
NTLA Investors are Reminded of the Final Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Malaysian Reserve
NTLA Lawsuit Alert! Class Action Lawsuit Against Intellia Therapeutics Inc. - TipRanks
Intellia Therapeutics, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before April 14, 2025 to Discuss Your RightsNTLA - PR Newswire
NTLA Deadline: NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit - Morningstar
FINAL NTLA DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Intellia Therapeutics, Inc. Investors to Join the Class Action Lawsuit - markets.businessinsider.com
0.39%
3.66%
자본화:
|
볼륨(24시간):